{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T04:45:05Z","timestamp":1776919505442,"version":"3.51.2"},"reference-count":27,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Italian Ministry of Health","doi-asserted-by":"crossref","award":["L03P03"],"award-info":[{"award-number":["L03P03"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>Background: Population-level evidence on delivery of neuro-oncology care is essential for evaluating access, equity, and quality of treatment pathways. However, real-world data describing how patients with central nervous system (CNS) tumors, especially with glioblastoma, are managed across healthcare systems remain limited. This study aimed to characterize treatment pathways using linked registry and administrative data within a regional care network. Methods: All adult CNS tumors diagnosed between 2016 and 2020 were identified in the Veneto Cancer Registry. Tumor grading was derived using a validated text-mining algorithm, and surgical, radiotherapy, and systemic treatments were captured through linkage with regional healthcare utilization databases. Patterns of care were evaluated by tumor subtype, grade, and diagnostic pathway. Results: Among 1634 histologically confirmed tumors, glioblastoma represented the largest group. Surgical intervention was widely implemented, with high resection rates in glioblastoma and meningioma. Combined chemoradiotherapy constituted the primary adjuvant approach for glioblastoma and high-grade diffuse gliomas, whereas management of lower-grade tumors showed greater variability. Approximately one-third of patients received no oncologic therapy, primarily associated with older age or diagnostic uncertainty. Analysis of recurrent glioblastoma showed heterogeneous systemic treatment use, reflecting evolving therapeutic practice. Conclusions: Linking population-based registry and administrative data provides actionable insight into real-world delivery of neuro-oncology care, in particular for glioblastoma patients. This approach enables monitoring of treatment variability, identification of potential access gaps, and evaluation of system-level performance, supporting data-driven planning of multidisciplinary services and future quality improvement initiatives.<\/jats:p>","DOI":"10.3390\/curroncol33040236","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T16:10:44Z","timestamp":1776787844000},"page":"236","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Real-World Treatment Pathways of Adult Patients with Glioblastoma and Other CNS Tumors: A Population-Based Registry Study"],"prefix":"10.3390","volume":"33","author":[{"given":"Eliana","family":"Ferroni","sequence":"first","affiliation":[{"name":"Veneto Cancer Registry, Epidemiological Department, Azienda Zero, 35132 Padua, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6528-5713","authenticated-orcid":false,"given":"Alessandra","family":"Andreotti","sequence":"additional","affiliation":[{"name":"Veneto Cancer Registry, Epidemiological Department, Azienda Zero, 35132 Padua, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4908-5506","authenticated-orcid":false,"given":"Stefano","family":"Guzzinati","sequence":"additional","affiliation":[{"name":"Veneto Cancer Registry, Epidemiological Department, Azienda Zero, 35132 Padua, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanna","family":"Baracco","sequence":"additional","affiliation":[{"name":"Veneto Cancer Registry, Epidemiological Department, Azienda Zero, 35132 Padua, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maddalena","family":"Baracco","sequence":"additional","affiliation":[{"name":"Veneto Cancer Registry, Epidemiological Department, Azienda Zero, 35132 Padua, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuela","family":"Bovo","sequence":"additional","affiliation":[{"name":"Veneto Cancer Registry, Epidemiological Department, Azienda Zero, 35132 Padua, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Carpin","sequence":"additional","affiliation":[{"name":"Veneto Cancer Registry, Epidemiological Department, Azienda Zero, 35132 Padua, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Dal Cin","sequence":"additional","affiliation":[{"name":"Veneto Cancer Registry, Epidemiological Department, Azienda Zero, 35132 Padua, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Greco","sequence":"additional","affiliation":[{"name":"Veneto Cancer Registry, Epidemiological Department, Azienda Zero, 35132 Padua, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Rita","family":"Fiore","sequence":"additional","affiliation":[{"name":"Veneto Cancer Registry, Epidemiological Department, Azienda Zero, 35132 Padua, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Memo","sequence":"additional","affiliation":[{"name":"Veneto Cancer Registry, Epidemiological Department, Azienda Zero, 35132 Padua, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9656-6695","authenticated-orcid":false,"given":"Daniele","family":"Monetti","sequence":"additional","affiliation":[{"name":"Veneto Cancer Registry, Epidemiological Department, Azienda Zero, 35132 Padua, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Rizzato","sequence":"additional","affiliation":[{"name":"Veneto Cancer Registry, Epidemiological Department, Azienda Zero, 35132 Padua, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica Elisabeth","family":"Stocco","sequence":"additional","affiliation":[{"name":"Veneto Cancer Registry, Epidemiological Department, Azienda Zero, 35132 Padua, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Stocco","sequence":"additional","affiliation":[{"name":"Veneto Cancer Registry, Epidemiological Department, Azienda Zero, 35132 Padua, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Zamberlan","sequence":"additional","affiliation":[{"name":"Veneto Cancer Registry, Epidemiological Department, Azienda Zero, 35132 Padua, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Maccari","sequence":"additional","affiliation":[{"name":"Department of Oncology, Oncology 1, Veneto Institute of Oncology IOV-IRCCS, 35128 Padua, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Bosio","sequence":"additional","affiliation":[{"name":"Department of Oncology, Oncology 1, Veneto Institute of Oncology IOV-IRCCS, 35128 Padua, Italy"},{"name":"Department of Surgery, Oncology and Gastroenterology, University of Padua, 35128 Padua, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2529-6149","authenticated-orcid":false,"given":"Luca","family":"Denaro","sequence":"additional","affiliation":[{"name":"Academic Neurosurgery, Department of Neurosciences, University of Padua, 35128 Padua, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giampietro","family":"Pinna","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, AOUI Borgo Trento Hospital, 37124 Verona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7593-8138","authenticated-orcid":false,"given":"Sara","family":"Lonardi","sequence":"additional","affiliation":[{"name":"Department of Oncology, Oncology 1, Veneto Institute of Oncology IOV-IRCCS, 35128 Padua, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1316-2132","authenticated-orcid":false,"given":"Giuseppe","family":"Lombardi","sequence":"additional","affiliation":[{"name":"Department of Oncology, Oncology 1, Veneto Institute of Oncology IOV-IRCCS, 35128 Padua, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6025-5214","authenticated-orcid":false,"given":"Manuel","family":"Zorzi","sequence":"additional","affiliation":[{"name":"Veneto Cancer Registry, Epidemiological Department, Azienda Zero, 35132 Padua, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"key":"ref_1","unstructured":"Ferlay, J., Laversanne, M., Ervik, M., Lam, F., Colombet, M., Mery, L., Pi\u00f1eros, M., Znaor, A., Soerjomataram, I., and Bray, F. (2024). Global Cancer Observatory: Cancer Tomorrow (Version 1.1), International Agency for Research on Cancer. Available online: https:\/\/gco.iarc.who.int\/tomorrow."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0140-6736(18)30990-5","article-title":"Primary brain tumours in adults","volume":"392","author":"Lapointe","year":"2018","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.ejca.2011.12.013","article-title":"Epidemiology of glial and non-glial brain tumours in Europe","volume":"48","author":"Crocetti","year":"2012","journal-title":"Eur. J. Cancer"},{"key":"ref_4","unstructured":"AIOM, AIRTUM, Fondazione AIOM, ONS, PASSI, and PASSI d\u2019Argento e SIAPeC-IAP (2023). I Numeri del Cancro in Italia 2023, AIOM."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11060-025-05257-w","article-title":"Incidence and survival of adult central nervous system tumors in the Veneto region: A population-based registry study (2016\u20132020)","volume":"176","author":"Andreotti","year":"2025","journal-title":"J. Neurooncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1097\/00006123-199805000-00054","article-title":"Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumors","volume":"42","author":"Sawaya","year":"1998","journal-title":"Neurosurgery"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 world health organization classification of tumors of the central nervous system: A summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol."},{"key":"ref_8","unstructured":"U.S. Department of Health and Human Services (1997). International Classification of Diseases, 9th Revision, Clinical Modifications (ICD-9-CM), Health Care Financing Administration. [6th ed.]. DHHS Publication No. (PHS) 96-1260."},{"key":"ref_9","unstructured":"R Core Team (2023). R: A Language and Environment for Statistical Computing, R Foundation for Statistical Computing. Available online: https:\/\/www.R-project.org\/."},{"key":"ref_10","unstructured":"SAS Institute Inc (2020). SAS Enterprise Guide 8.3, SAS Institute Inc."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"New Engl. J. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e315","DOI":"10.1016\/S1470-2045(17)30194-8","article-title":"EANO guidelines on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas","volume":"18","author":"Weller","year":"2017","journal-title":"Lancet Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/noad149","article-title":"CBTRUS statistical report: Primary brain and other CNS tumors diagnosed in the United States in 2016\u20132020","volume":"25","author":"Ostrom","year":"2023","journal-title":"Neuro Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1056\/NEJMoa1611977","article-title":"Short-course radiation plus temozolomide in elderly patients with glioblastoma","volume":"376","author":"Perry","year":"2017","journal-title":"New Engl. J. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1002\/cncr.27590","article-title":"Conditional probability of long-term survival in glioblastoma: A population-based analysis","volume":"118","author":"Johnson","year":"2012","journal-title":"Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Lombardi, G., Bergo, E., Caccese, M., Padovan, M., and Zagonel, V. (2019). Validation of the comprehensive geriatric assessment as a predictor of mortality in elderly glioblastoma patients. Cancers, 11.","DOI":"10.3390\/cancers11101509"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/S1470-2045(16)30313-8","article-title":"Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033\u201326033): A randomized phase 3 study","volume":"17","author":"Baumert","year":"2016","journal-title":"Lancet Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1200\/JCO.2012.43.2229","article-title":"Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendro-glioma: Long-term follow-up of EORTC brain tumor group study 26951","volume":"31","author":"Brandes","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJMoa2304194","article-title":"Vorasidenib in IDH1- or IDH2-mutant low-grade glioma","volume":"389","author":"Mellinghoff","year":"2023","journal-title":"New Engl. J. Med."},{"key":"ref_20","first-page":"2530","article-title":"Postoperative radiotherapy for atypical meningioma: Patterns of care and outcomes from NRG Oncology\/RTOG 0539","volume":"39","author":"Rogers","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"ref_21","first-page":"e281","article-title":"EANO guideline on the diagnosis and management of meningiomas","volume":"22","author":"Goldbrunner","year":"2021","journal-title":"Lancet Oncol."},{"key":"ref_22","unstructured":"National Comprehensive Cancer Network (2025). Central Nervous System Cancers; Version 1.2025; NCCN Clinical Practice Guidelines in Oncology 2025, National Comprehensive Cancer Network."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Bosio, A., Maccari, M., Padovan, M., Caccese, M., Bolshinsky, M., Galiano, A., Cavallin, F., Bellu, L., Pasqualetti, F., and Parisi, A. (2025). Real-world management and long-term outcomes in adolescent, young adult, and adult medulloblastoma: Experience from a monocentric series with multimodal and targeted approaches. Neuro-Oncol. Pract., npaf110.","DOI":"10.1093\/nop\/npaf110"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0360-3016(03)00643-6","article-title":"The treatment of adults with medulloblastoma: A prospective study","volume":"57","author":"Brandes","year":"2003","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Minniti, G., Lombardi, G., and Paolini, S. (2019). Glioblastoma in Elderly Patients: Current Management and Future Perspectives. Cancers, 11.","DOI":"10.3390\/cancers11030336"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1093\/neuonc\/noac217","article-title":"Global survival trends for brain tumors, by histology: CONCORD-3 analysis","volume":"25","author":"Girardi","year":"2023","journal-title":"Neuro Oncol."},{"key":"ref_27","unstructured":"(2026, March 12). Presidential Decree No. 106, 21 July 2025. Approval of the Diagnostic-Therapeutic Care Pathway (PDTA) for Patients with Central Nervous System Tumors\u2014Edition 2:2025. Available online: https:\/\/salute.regione.veneto.it\/rete-oncologica-veneta-%28rov%29\/area-operatori\/pdta-tumori-cerebrali."}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/33\/4\/236\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T04:18:24Z","timestamp":1776917904000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/33\/4\/236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":27,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["curroncol33040236"],"URL":"https:\/\/doi.org\/10.3390\/curroncol33040236","relation":{},"ISSN":["1718-7729"],"issn-type":[{"value":"1718-7729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]}}}